STSS Sharps Technology Inc.

Sharps Technology Inc.

Medical/Dental Instruments

Health Care

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

IPO Year: 2022

Exchange: NASDAQ

Website: https://sharpstechnology.com

Recent Analyst Ratings for Sharps Technology Inc.

Date	Price Target	Rating	Analyst

See more ratings

Sharps Technology Inc.

Recent Analyst Ratings for Sharps Technology Inc.

Sharps Technology Inc. Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Hayes Robert Michael bought $10,750 worth of shares (300,000 units at $0.04), increasing direct ownership by 297% to 400,882 units (SEC Form 4)

Amendment: Chief Executive Officer Hayes Robert Michael bought $10,072 worth of shares (5,000 units at $2.01), increasing direct ownership by 115% to 9,358 units (SEC Form 4)

Chief Executive Officer Hayes Robert Michael bought $10,072 worth of shares (5,000 units at $2.01), increasing direct ownership by 5% to 100,882 units (SEC Form 4)

Hayes Robert Michael bought $3,400 worth of shares (10,000 units at $0.34), increasing direct ownership by 12% to 95,882 units (SEC Form 4)

Hayes Robert Michael bought $2,900 worth of shares (10,000 units at $0.29), increasing direct ownership by 13% to 85,882 units (SEC Form 4)

Hayes Robert Michael bought $3,646 worth of shares (10,200 units at $0.36), increasing direct ownership by 16% to 75,882 units (SEC Form 4)

Ruemler Timothy James bought $3,786 worth of shares (9,466 units at $0.40), increasing direct ownership by 0.90% to 1,061,675 units (SEC Form 4)

Crescenzo Andrew R. bought $1,476 worth of shares (3,500 units at $0.42), increasing direct ownership by 29% to 15,500 units (SEC Form 4)

Ruemler Timothy James bought $4,016 worth of shares (10,000 units at $0.40), increasing direct ownership by 0.96% to 1,052,209 units (SEC Form 4)

Ruemler Timothy James bought $4,500 worth of shares (10,000 units at $0.45), increasing direct ownership by 0.97% to 1,042,209 units (SEC Form 4)